EAU Guidelines on Urethral Carcinoma II
Explore this #EAUUrologyCheatSheet, spotlighting #PrimaryUrethralCarcinoma. It’s a complete guide for managing this condition. Check it out now! #EAUguidelines
Explore this #EAUUrologyCheatSheet, spotlighting #PrimaryUrethralCarcinoma. It’s a complete guide for managing this condition. Check it out now! #EAUguidelines
Our latest #UrologyCheatSheet is here, bringing together the key genital lesions caused by sexually transmitted infections. The most common agents are human papillomavirus, herpes simplex virus, and Treponema pallidum. Dive into essential information and guidance for diagnosis and treatment.
Urolithiasis treatment is based on many parameters and is individualised for each patient, whether it is renal colic or an obstruction. Review the disease management #EAUGuidelines in this #EAUUrologyCheatSheets on #Urolithiasis.
This #EAUUrologyCheatSheets is a review of the #EAUGuidelines for the treatment of #ProstateCancer. It represents a collaborative effort between the EAU and numerous partners to provide a concise yet comprehensive overview of treatment pathways.
In this #EAUUrologyCheatSheets you can review both the conservative and pharmacological treatment options for Male LUTS. Download the sheet and review the #EAUGuidelines on #MaleLUTS disease management!
In this Urology Cheat Sheet, we will explore the impact of Benign Prostatic Hyperplasia (BPH) surgery on sexual function. Don’t miss it!!
Dive into our new #EAUUrologyCheatSheets focusing on non-muscle invasive bladder cancer #NMIBC. Learn more about risk stratification and disease management – essential resources for improving patient care. #BladderCancer
Recurrent UTIs (rUTIs) include both cystitis and pyelonephritis, but repeated pyelonephritis should prompt the consideration of complicated aetiology. Review the #EAUGuidelines on #UTI (recurrent urinary tract infections and uncomplicated pyelonephritis ) with this #EAUUrologyCheatSheets!
Our newest #EAUUrologyCheatSheets is a collaborative effort with @ASCO to create comprehensive guidelines on #PenileCancer. Review the updated #EAUGuidelines on #PenileCarcinoma with this one page cheat sheet!
BCG is an effective treatment for high-risk non-muscle invasive bladder tumors, with response rates of around 70%. However, progression during BCG treatment can occur in 9.5%-21% of cases, resulting in a worse patient prognosis. If there is no response to BCG or BCG failure occurs, the European Association of Urology (EAU) guidelines have defined different …